304 related articles for article (PubMed ID: 15927672)
1. Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis.
Kakumitsu H; Kamezaki K; Shimoda K; Karube K; Haro T; Numata A; Shide K; Matsuda T; Oshima K; Harada M
Leuk Res; 2005 Jul; 29(7):761-9. PubMed ID: 15927672
[TBL] [Abstract][Full Text] [Related]
2. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation.
Yan XQ; Lacey D; Hill D; Chen Y; Fletcher F; Hawley RG; McNiece IK
Blood; 1996 Jul; 88(2):402-9. PubMed ID: 8695786
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO.
Chagraoui H; Tulliez M; Smayra T; Komura E; Giraudier S; Yun T; Lassau N; Vainchenker W; Wendling F
Blood; 2003 Apr; 101(8):2983-9. PubMed ID: 12506018
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral-mediated TGF-beta1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis development.
Gastinne T; Vigant F; Lavenu-Bombled C; Wagner-Ballon O; Tulliez M; Chagraoui H; Villeval JL; Lacout C; Perricaudet M; Vainchenker W; Benihoud K; Giraudier S
Exp Hematol; 2007 Jan; 35(1):64-74. PubMed ID: 17198875
[TBL] [Abstract][Full Text] [Related]
5. Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis.
Frey BM; Rafii S; Teterson M; Eaton D; Crystal RG; Moore MA
J Immunol; 1998 Jan; 160(2):691-9. PubMed ID: 9551904
[TBL] [Abstract][Full Text] [Related]
6. Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin.
Wagner-Ballon O; Chagraoui H; Prina E; Tulliez M; Milon G; Raslova H; Villeval JL; Vainchenker W; Giraudier S
J Immunol; 2006 Jun; 176(11):6425-33. PubMed ID: 16709799
[TBL] [Abstract][Full Text] [Related]
7. [Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis].
Frey BM; Rafii S; Crystal RG; Moore MA
Schweiz Med Wochenschr; 1998 Oct; 128(42):1587-92. PubMed ID: 9824887
[TBL] [Abstract][Full Text] [Related]
8. [Thrombopoietin is a multifunctional factor].
Hino M
Rinsho Byori; 1997 Oct; 45(10):921-6. PubMed ID: 9369068
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of myelofibrosis with myeloid metaplasia.
Tefferi A
J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin, a direct stimulator of viability and multilineage growth of primitive bone marrow progenitor cells.
Jacobsen SE; Borge OJ; Ramsfjell V; Cui L; Cardier JE; Veiby OP; Murphy MJ; Lok S
Stem Cells; 1996; 14 Suppl 1():173-80. PubMed ID: 11012218
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin gene transfer-mediated enhancement of angiogenic responses to acute ischemia.
Amano H; Hackett NR; Rafii S; Crystal RG
Circ Res; 2005 Aug; 97(4):337-45. PubMed ID: 16051888
[TBL] [Abstract][Full Text] [Related]
12. Major effects of TPO delivered by a single injection of a recombinant adenovirus on prevention of septicemia and anemia associated with myelosuppression in mice: risk of sustained expression inducing myelofibrosis due to immunosuppression.
Abina MA; Tulliez M; Lacout C; Debili N; Villeval JL; Pflumio F; Wendling F; Vainchenker W; Haddada H
Gene Ther; 1998 Apr; 5(4):497-506. PubMed ID: 9614574
[TBL] [Abstract][Full Text] [Related]
13. Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro.
Taguchi K; Saitoh M; Arai Y; Momose K; Ogawa Y; Yasuda S; Miyata K
Cytokine; 2001 Sep; 15(5):241-9. PubMed ID: 11594788
[TBL] [Abstract][Full Text] [Related]
14. Impact of chicken thrombopoietin and its receptor c-Mpl on hematopoietic cell development.
Bartunek P; Karafiat V; Bartunkova J; Pajer P; Dvorakova M; Kralova J; Zenke M; Dvorak M
Exp Hematol; 2008 Apr; 36(4):495-505. PubMed ID: 18243490
[TBL] [Abstract][Full Text] [Related]
15. Macrophage derived signalling regulates negatively the megakaryocyte compartment.
Landoni VI; Vermeulen M; Van Rooijen N; Gómez S; Palermo M; Isturiz MA; Alves-Rosa F
Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL667-75. PubMed ID: 15607047
[TBL] [Abstract][Full Text] [Related]
16. Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG).
Wang JC; Hemavathy K; Charles W; Zhang H; Dua PK; Novetsky AD; Chang T; Wong C; Jabara M
Exp Hematol; 2004 Oct; 32(10):905-10. PubMed ID: 15504545
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice.
Wagner-Ballon O; Pisani DF; Gastinne T; Tulliez M; Chaligné R; Lacout C; Auradé F; Villeval JL; Gonin P; Vainchenker W; Giraudier S
Blood; 2007 Jul; 110(1):345-53. PubMed ID: 17374740
[TBL] [Abstract][Full Text] [Related]
18. Support of hMSCs transduced with TPO/FL genes to expansion of umbilical cord CD34+ cells in indirect co-culture.
Xie C; Jia B; Xiang Y; Wang L; Wang G; Huang G; McNiece IK; Wang J
Cell Tissue Res; 2006 Oct; 326(1):101-10. PubMed ID: 16685532
[TBL] [Abstract][Full Text] [Related]
19. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis.
Vannucchi AM; Bianchi L; Paoletti F; Pancrazzi A; Torre E; Nishikawa M; Zingariello M; Di Baldassarre A; Rana RA; Lorenzini R; Alfani E; Migliaccio G; Migliaccio AR
Blood; 2005 May; 105(9):3493-501. PubMed ID: 15665119
[TBL] [Abstract][Full Text] [Related]
20. Chronic thrombopoietin overexpression induces mesangioproliferative glomerulopathy in mice.
Shimoda HK; Yamamoto M; Shide K; Kamezaki K; Matsuda T; Ogawa K; Harada M; Shimoda K
Am J Hematol; 2007 Sep; 82(9):802-6. PubMed ID: 17546634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
